甲状腺乳头状癌流行病学及诊疗焦点探讨OACSTPCD
Epidemiology and diagnosis and treatment focus of papillary thyroid carcinoma
甲状腺癌发病率全球范围内呈快速上升趋势,学术界对其原因观点不一,有部分学者认为其为"过度诊断"导致,但从大样本流行病学研究来看,其发病率为真实上升.国外最新文献报告,美国甲状腺癌死亡率呈上升趋势,其原因可能与美国甲状腺学会(ATA)指南对于甲状腺乳头状癌诊疗降级相关;而持更积极诊疗态度的韩国等亚洲国家死亡率呈逐年下降趋势,这需要我们注意与深思.因此本文对甲状腺乳头状癌流行病学及国内外诊疗焦点再次探讨.我国甲状腺癌5年生存率从2003-2005年的67.5％增长至2012-2015年的84.3％,出现显著提升,然而仍远低于美国的98.3％.针对如今我国甲状腺癌同质化诊断、治疗水平低的现状,直接照搬国外指南,诊疗降级,存在引起我国甲状腺癌死亡率上升的风险.
The incidence rate of thyroid cancer is rising rapidly worldwide,and the academic community has different views on its causes.Some believe that thyroid cancer is caused by over-diagnosis,but according to a large sample of epidemiological studies,its incidence rate is rising.The latest study reports that the mortality rate of thyroid cancer in the United States is on the rise,which may be related to the downgrade of diagnosis and treatment for papillary thyroid cancer according to the ATA guidelines.The mortality rate in Asian countries such as South Korea is showing a decreasing trend over time,which might be related to the active diagnosis and treatment measures.The 5-year survival rate of thyroid cancer in China has increased from 67.5％in 2003-2005 to 84.3％in 2012-2015,which still lags far behind 98.3％in the United States.Considering the differences in homogeneous diagnosis and treatment of thyroid cancer in China,if we blindly follow the guidelines of other countries,it may lead to an increase in the mortality rate of thyroid cancer in China.
田文;阳泽龙
解放军总医院普通外科医学部甲状腺(疝)外科,北京 100853
临床医学
甲状腺微小乳头状癌流行病学积极监测射频消融
papillary thyroid carcinomaepidemiologyactive surveillanceradiofrequency ablation
《西安交通大学学报（医学版）》 2024 (001)
44-48 / 5
评论